News Channels

16 Oct 2017 Opdivo Alone or Combined with Yervoy Shows Encouraging Response and Survival Rates in Recurrent Small Cell Lung Cancer Patients with High Tumor Mutation Burden, in Exploratory Analysis from Phase 1/2 Study CheckMate -032
16 Oct 2017 ANTABIO Raises € 7.3M Series A Financing to Develop Novel Treatments against Drug-Resistant Gram-Negative Infections
14 Oct 2017 Janssen Announces U.S. FDA Approval Of STELARA® (ustekinumab) For The Treatment Of Adolescents With Moderate To Severe Plaque Psoriasis
14 Oct 2017 Faslodex (fulvestrant) receives positive CHMP opinion for the treatment of hormone receptor-positive advanced breast cancer in combination with palbociclib1
14 Oct 2017 CHMP recommends EU approval of Roche’s Alecensa (alectinib) as a first-line treatment for people with ALK-positive NSCLC
13 Oct 2017 Prometic Announces FDA Acceptance of its Biologics License Application for Plasminogen (Ryplazim™)
13 Oct 2017 CHMP Issues a Positive Opinion on Janssen’s ZYTIGA® to Include Earlier Stage Prostate Cancer Patients
13 Oct 2017 Elsalys Biotech acquires from Jazz Pharmaceuticals the worldwide rights of Leukotac®
13 Oct 2017 FDA Advisory Committee Unanimously Recommends Approval of Investigational LUXTURNA™ (voretigene neparvovec) for Patients with Biallelic RPE65-mediated Inherited Retinal Disease
13 Oct 2017 miRagen Therapeutics Presents New Clinical Data Suggesting Positive Impact From Systemically Administered MRG-106 on Mycosis Fungoides Form of Cutaneous T-Cell Lymphoma at EORTC Global Task Force Meeting
13 Oct 2017 Ionis Pharmaceuticals Initiates Clinical Study of IONIS-MAPT Rx in Patients with Alzheimer's Disease
12 Oct 2017 Spinal Muscular Atrophy Program Advances into Pivotal Study in SMA Patients
12 Oct 2017 Vidac Pharma Reports Positive Results from Phase 2a Proof-of-Concept Trial of VDA-1102 Ointment in Actinic Keratosis
12 Oct 2017 Merz and Teijin Announce Partnership to Bring Xeomin® (incobotulinumtoxinA) to Japan
12 Oct 2017 U.S. FDA Approves LYRICA® CR (pregabalin) Extended-Release Tablets CV
12 Oct 2017 Codexis and Nestlé Health Science Enter Into Healthcare-Focused Protein Engineering Platform Partnership
12 Oct 2017 Zealand has initiated a clinical trial to evaluate the potential for less than once-daily dosing with its long-acting GLP-2 analog glepaglutide
12 Oct 2017 FDA Grants Priority Review for Potential New Indication for Lilly's Verzenio(TM) (abemaciclib) as Initial Treatment of Advanced Breast Cancer
12 Oct 2017 Ardelyx's Pivotal Phase 3 Study of Tenapanor for IBS-C Hits Primary and All Secondary Endpoints to Support NDA Submission in 2018
12 Oct 2017 Otsuka and Lundbeck Announce Initiation of Two Phase 3 Trials of Brexpiprazole in Patients with Bipolar I Disorder

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing